[
  {
    "ts": null,
    "headline": "What Does Wall Street Think About Bristol-Myers Squibb (BMY)?",
    "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is one of the best drug stocks to buy right now. On September 8, BMO Capital analyst Evan Seigerman maintained a Hold rating on Bristol-Myers Squibb Company (NYSE:BMY), retaining the price target of $47.00. The analyst attributed the rating to the performance of Cobenfy, the company’s new product, in the market, […]",
    "url": "https://finnhub.io/api/news?id=65e087726317b8d359a9388372d3376b934a889f75f9d4f7ad0c9b7062add79b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758052702,
      "headline": "What Does Wall Street Think About Bristol-Myers Squibb (BMY)?",
      "id": 136782190,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is one of the best drug stocks to buy right now. On September 8, BMO Capital analyst Evan Seigerman maintained a Hold rating on Bristol-Myers Squibb Company (NYSE:BMY), retaining the price target of $47.00. The analyst attributed the rating to the performance of Cobenfy, the company’s new product, in the market, […]",
      "url": "https://finnhub.io/api/news?id=65e087726317b8d359a9388372d3376b934a889f75f9d4f7ad0c9b7062add79b"
    }
  },
  {
    "ts": null,
    "headline": "Bristol-Myers Squibb Company (BMY)-BioNTech Lung Cancer Therapy Shows 76% Tumor Reduction",
    "summary": "In this article, we will be taking a look at the 12 Cheap Healthcare Stocks to Buy Now. Bristol-Myers Squibb Company stands fifth among them. Bristol-Myers Squibb Company (NYSE:BMY), a global biopharmaceutical leader, specializes in oncology, immunology, cardiovascular, hematology, and neuroscience therapies, with blockbuster drugs including Eliquis and Opdivo. In July 2025, Bristol-Myers Squibb Company (NYSE:BMY) […]",
    "url": "https://finnhub.io/api/news?id=2283a994bcef0372994234a08b2324687fe30adb58319f382c56119c7fc0a897",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758032877,
      "headline": "Bristol-Myers Squibb Company (BMY)-BioNTech Lung Cancer Therapy Shows 76% Tumor Reduction",
      "id": 136773585,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "In this article, we will be taking a look at the 12 Cheap Healthcare Stocks to Buy Now. Bristol-Myers Squibb Company stands fifth among them. Bristol-Myers Squibb Company (NYSE:BMY), a global biopharmaceutical leader, specializes in oncology, immunology, cardiovascular, hematology, and neuroscience therapies, with blockbuster drugs including Eliquis and Opdivo. In July 2025, Bristol-Myers Squibb Company (NYSE:BMY) […]",
      "url": "https://finnhub.io/api/news?id=2283a994bcef0372994234a08b2324687fe30adb58319f382c56119c7fc0a897"
    }
  },
  {
    "ts": null,
    "headline": "These 4 Measures Indicate That Bristol-Myers Squibb (NYSE:BMY) Is Using Debt Reasonably Well",
    "summary": "The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...",
    "url": "https://finnhub.io/api/news?id=0e74178e5487c376f01d66a968936b86b34446f05683537eabb4e0d531bc41c3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758031208,
      "headline": "These 4 Measures Indicate That Bristol-Myers Squibb (NYSE:BMY) Is Using Debt Reasonably Well",
      "id": 136773586,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...",
      "url": "https://finnhub.io/api/news?id=0e74178e5487c376f01d66a968936b86b34446f05683537eabb4e0d531bc41c3"
    }
  },
  {
    "ts": null,
    "headline": "K36 Therapeutics Provides Clinical Update on KTX-1001 in Multiple Myeloma",
    "summary": "K36 Therapeutics, Inc. (\"K36\"), a privately held clinical-stage biotechnology company developing novel, targeted therapies for cancers with unmet medical need, today provided a clinical update on its lead asset, KTX-1001 for multiple myeloma (MM).",
    "url": "https://finnhub.io/api/news?id=207c080e8b78e739f0230fea9a70b47c902bc3a7104f048d16883a98951a22a4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758024000,
      "headline": "K36 Therapeutics Provides Clinical Update on KTX-1001 in Multiple Myeloma",
      "id": 136773587,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "K36 Therapeutics, Inc. (\"K36\"), a privately held clinical-stage biotechnology company developing novel, targeted therapies for cancers with unmet medical need, today provided a clinical update on its lead asset, KTX-1001 for multiple myeloma (MM).",
      "url": "https://finnhub.io/api/news?id=207c080e8b78e739f0230fea9a70b47c902bc3a7104f048d16883a98951a22a4"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers Squibb to Participate in the Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum",
    "summary": "PRINCETON, N.J., September 16, 2025--Bristol Myers Squibb to Participate in the Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum",
    "url": "https://finnhub.io/api/news?id=8bf9584a46524313599f354e6f54169e8936c5cfcf55a49a233c4739c508eaa0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758023940,
      "headline": "Bristol Myers Squibb to Participate in the Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum",
      "id": 136773588,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "PRINCETON, N.J., September 16, 2025--Bristol Myers Squibb to Participate in the Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum",
      "url": "https://finnhub.io/api/news?id=8bf9584a46524313599f354e6f54169e8936c5cfcf55a49a233c4739c508eaa0"
    }
  },
  {
    "ts": null,
    "headline": "10 Quality High Yield In Rose's Income Garden Portfolio: 5 Winners To Buy",
    "summary": "10 Quality High Yield In Rose's Income Garden Portfolio: 5 Winners To Buy",
    "url": "https://finnhub.io/api/news?id=742a181eed65f73bad939c2b1752b11c109c3928c33e11bcca9095c1a3cdbfd3",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758019618,
      "headline": "10 Quality High Yield In Rose's Income Garden Portfolio: 5 Winners To Buy",
      "id": 136772542,
      "image": "",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=742a181eed65f73bad939c2b1752b11c109c3928c33e11bcca9095c1a3cdbfd3"
    }
  },
  {
    "ts": null,
    "headline": "These stock-market experts don’t love AI. Here’s what they do recommend.",
    "summary": "These stock-market experts don’t love AI. Here’s what they do recommend.",
    "url": "https://finnhub.io/api/news?id=3a9c3f0bdff234add8d45a1839a734140909d818fb98932f8a87354f67784470",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758007800,
      "headline": "These stock-market experts don’t love AI. Here’s what they do recommend.",
      "id": 136778866,
      "image": "",
      "related": "BMY",
      "source": "MarketWatch",
      "summary": "These stock-market experts don’t love AI. Here’s what they do recommend.",
      "url": "https://finnhub.io/api/news?id=3a9c3f0bdff234add8d45a1839a734140909d818fb98932f8a87354f67784470"
    }
  }
]